$ECHO

BYE STEPHEN J sold $764K of ECHO

BYE STEPHEN J sold 8,508 shares of EchoStar CORP (ECHO) at an average of $89.83 ($89.73–$89.90, $0.76M total) across 2 trades on 2026-08-07.

Original reporting
SEC EDGAR · BYE STEPHEN J
Published Aug 11, 2026, 10:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ECHO
Neutral
medium confidence
Mentioned
$ECHO
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ECHONeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale of 8,508 shares at about $89.83 weighted average, leaving 653 shares after the transaction.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone does not change fundamentals based on the provided text.

03

What to watch

The article provides only the sale details; it does not include context such as prior grants, tax planning, or whether other insiders are selling or buying around the same period.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-11, covering sales executed 2026-08-07

Background

This is an SEC Form 4 insider transaction disclosure for EchoStar Corp, reported by director BYE Stephen J.

Company-level read

Ticker impact

$ECHONeutralMedium confidence
Context

EchoStar director BYE Stephen J filed a Form 4 selling 8,508 shares in open-market trades worth about $764K on 2026-08-07.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless repeated or paired with other disclosures.

Evidence & confidence

Form 4 insider sales are common and this transaction is moderate in size relative to typical daily liquidity, with no accompanying guidance, deal, or regulatory action in the text.

Market effects

No sector-level signal is provided beyond a single insider transaction.

None indicated.

None indicated.

Counterpoint

Because the filing states no pre-arranged 10b5-1 plan, some traders may interpret it as higher near-term risk, even though insider sales are often discretionary.

Key entities

  • EchoStar Corp

    Subject of the Form 4 insider sale disclosure.

  • BYE Stephen J

    Director who sold 8,508 shares in two trades on 2026-08-07.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WMGMed

Morgan Stanley Names Some Of Its Buys as Wall Street Spots Opportunity in Beaten-Down Stocks

Morgan Stanley identified Warner Music Group, Darden Restaurants, SiTime, and EchoStar as attractive investment opportunities. Analysts highlighted Warner Music's catalog value (> $30 per share) and strong Q3 results (revenue $1.86B, up 10%). Darden's price target was raised to $255. EchoStar was noted for its SpaceX exposure and spectrum holdings. SiTime was also recommended.

$AAPLMed

Apple, Compass Pathways, Aritzia and more analyst calls of the week

Dell shares rose 11% to a record high after RBC initiated coverage with an Outperform rating and $640 target, citing strong AI and PC demand. Apple shares gained 3.1% after unveiling its first foldable iPhone, the iPhone Duo, priced at $1,999 and above. AstraZeneca's shares remained flat despite mixed analyst views on its drug tozorakimab. Compass Pathways shares climbed 4% on positive Phase III study data for its psilocybin treatment.